US Stock MarketDetailed Quotes

Ironwood Pharmaceuticals (IRWD)

Watchlist
  • 3.930
  • +0.140+3.69%
Close Apr 24 15:59 ET
  • 3.900
  • -0.030-0.76%
Post 19:38 ET
640.82MMarket Cap26.20P/E (TTM)

Ironwood Pharmaceuticals (IRWD) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
22.69%127.04M
390.17%74.58M
381.37%47.58M
-145.03%-15.07M
-55.64%19.95M
-43.55%103.55M
-57.54%15.21M
-69.55%9.89M
-4.28%33.47M
-43.89%44.99M
Net income from continuing operations
2,629.20%24.02M
-200.89%-2.28M
999.29%40.08M
2,844.07%23.6M
-798.27%-37.39M
100.09%880K
229.28%2.26M
-73.86%3.65M
99.92%-860K
-109.10%-4.16M
Operating gains losses
18.67%89K
---3K
40.00%7K
----
----
494.74%75K
--0
--5K
--37K
273.68%33K
Depreciation and amortization
-6.46%1.88M
-5.15%460K
-6.31%475K
-7.71%467K
-6.63%479K
27.68%2.01M
-5.27%485K
0.00%507K
87.41%506K
79.37%513K
Deferred tax
-40.08%40.8M
-104.25%-1.75M
261.57%27.77M
6.41%14.11M
-88.93%670K
-6.26%68.09M
31.23%41.1M
-46.12%7.68M
32.44%13.26M
-64.52%6.05M
Other non cash items
-12.39%1.67M
-12.69%-835K
13.59%844K
-10.80%834K
-14.68%825K
-99.83%1.9M
-113.26%-741K
26.79%743K
-99.91%935K
140.55%967K
Change In working capital
5,493.78%41.34M
331.55%75.15M
-128.61%-25.21M
-632.41%-58.68M
50.83%50.08M
-93.45%739K
-279.82%-32.46M
-132.32%-11.03M
-26.35%11.02M
245.64%33.2M
-Change in receivables
-25.59%35.15M
1,395.27%73.62M
-88.96%-34.19M
-433.62%-46.4M
-26.25%42.12M
5,012.12%47.24M
-24.19%-5.68M
-225.68%-18.1M
529.13%13.91M
299.41%57.11M
-Change in prepaid assets
312.36%367K
-52.12%1.09M
-169.47%-248K
-190.14%-64K
84.39%-407K
-97.89%89K
-62.83%2.27M
-91.86%357K
102.73%71K
28.95%-2.61M
-Change in payables and accrued expense
106.01%2.1M
93.02%-592K
245.48%9.53M
-115.76%-15.45M
139.17%8.61M
-635.86%-34.86M
-21.96%-8.48M
198.71%2.76M
-139.93%-7.16M
-1,208.93%-21.98M
-Change in other current assets
203.27%2.14M
6.75%1.79M
65.79%63K
113.76%143K
370.00%141K
-37.03%704K
313.58%1.68M
-86.38%38K
-1,891.38%-1.04M
-92.02%30K
-Change in other current liabilities
112.81%1.59M
96.61%-753K
-109.04%-354K
-41.14%3.09M
-159.60%-385K
-735.48%-12.43M
-531.35%-22.24M
468.49%3.92M
85.98%5.24M
131.54%646K
Cash from discontinued investing activities
Operating cash flow
22.69%127.04M
390.17%74.58M
381.37%47.58M
-145.03%-15.07M
-55.64%19.95M
-43.55%103.55M
-57.54%15.21M
-69.55%9.89M
-4.28%33.47M
-43.89%44.99M
Investing cash flow
Cash flow from continuing investing activities
76.06%-34K
1K
87.50%-2K
96.55%-2K
54.41%-31K
99.99%-142K
0
99.93%-16K
99.99%-58K
-423.08%-68K
Net PPE purchase and sale
76.06%-34K
--1K
87.50%-2K
96.55%-2K
54.41%-31K
47.99%-142K
--0
67.35%-16K
---58K
-423.08%-68K
Net business purchase and sale
----
----
----
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
76.06%-34K
--1K
87.50%-2K
96.55%-2K
54.41%-31K
99.99%-142K
--0
99.93%-16K
99.99%-58K
-423.08%-68K
Financing cash flow
Cash flow from continuing financing activities
100.20%216K
100.82%122K
0
100.18%88K
100.04%6K
-138.60%-106.97M
70.75%-14.89M
63.79%-27.16M
-112.37%-49.37M
-490.73%-15.56M
Net issuance payments of debt
--0
--0
--0
--0
--0
-138.33%-115M
40.00%-15M
66.67%-25M
-112.50%-50M
---25M
Net common stock issuance
----
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
-98.04%216K
-39.90%122K
--0
-88.25%88K
-99.94%6K
73.24%11.01M
-79.66%203K
--0
-45.17%749K
152.73%10.06M
Net other financing activities
----
----
----
----
----
89.78%-2.98M
99.67%-90K
---2.16M
---121K
---616K
Cash from discontinued financing activities
Financing cash flow
100.20%216K
100.82%122K
--0
100.18%88K
100.04%6K
-138.60%-106.97M
70.75%-14.89M
63.79%-27.16M
-112.37%-49.37M
-490.73%-15.56M
Net cash flow
Beginning cash position
-3.90%88.56M
59.17%140.41M
-12.01%92.85M
-10.74%108.48M
-3.90%88.56M
-85.99%92.15M
-20.86%88.21M
-40.25%105.52M
-83.62%121.54M
-85.99%92.15M
Current changes in cash
3,670.75%127.23M
22,743.43%74.7M
375.24%47.58M
6.16%-14.98M
-32.13%19.93M
99.37%-3.56M
101.70%327K
73.47%-17.29M
97.18%-15.97M
-65.10%29.36M
Effect of exchange rate changes
-928.13%-329K
1,571.43%351K
0.00%-26K
-1,168.63%-647K
-129.17%-7K
39.62%-32K
142.00%21K
-766.67%-26K
---51K
--24K
End cash Position
143.29%215.46M
143.29%215.46M
59.17%140.41M
-12.01%92.85M
-10.74%108.48M
-3.90%88.56M
-3.90%88.56M
-20.86%88.21M
-40.25%105.52M
-83.62%121.54M
Free cash flow
22.83%127.01M
390.18%74.58M
382.13%47.58M
-145.11%-15.07M
-55.64%19.92M
-43.54%103.41M
-57.29%15.21M
-69.55%9.87M
-4.45%33.41M
-43.96%44.92M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 22.69%127.04M390.17%74.58M381.37%47.58M-145.03%-15.07M-55.64%19.95M-43.55%103.55M-57.54%15.21M-69.55%9.89M-4.28%33.47M-43.89%44.99M
Net income from continuing operations 2,629.20%24.02M-200.89%-2.28M999.29%40.08M2,844.07%23.6M-798.27%-37.39M100.09%880K229.28%2.26M-73.86%3.65M99.92%-860K-109.10%-4.16M
Operating gains losses 18.67%89K---3K40.00%7K--------494.74%75K--0--5K--37K273.68%33K
Depreciation and amortization -6.46%1.88M-5.15%460K-6.31%475K-7.71%467K-6.63%479K27.68%2.01M-5.27%485K0.00%507K87.41%506K79.37%513K
Deferred tax -40.08%40.8M-104.25%-1.75M261.57%27.77M6.41%14.11M-88.93%670K-6.26%68.09M31.23%41.1M-46.12%7.68M32.44%13.26M-64.52%6.05M
Other non cash items -12.39%1.67M-12.69%-835K13.59%844K-10.80%834K-14.68%825K-99.83%1.9M-113.26%-741K26.79%743K-99.91%935K140.55%967K
Change In working capital 5,493.78%41.34M331.55%75.15M-128.61%-25.21M-632.41%-58.68M50.83%50.08M-93.45%739K-279.82%-32.46M-132.32%-11.03M-26.35%11.02M245.64%33.2M
-Change in receivables -25.59%35.15M1,395.27%73.62M-88.96%-34.19M-433.62%-46.4M-26.25%42.12M5,012.12%47.24M-24.19%-5.68M-225.68%-18.1M529.13%13.91M299.41%57.11M
-Change in prepaid assets 312.36%367K-52.12%1.09M-169.47%-248K-190.14%-64K84.39%-407K-97.89%89K-62.83%2.27M-91.86%357K102.73%71K28.95%-2.61M
-Change in payables and accrued expense 106.01%2.1M93.02%-592K245.48%9.53M-115.76%-15.45M139.17%8.61M-635.86%-34.86M-21.96%-8.48M198.71%2.76M-139.93%-7.16M-1,208.93%-21.98M
-Change in other current assets 203.27%2.14M6.75%1.79M65.79%63K113.76%143K370.00%141K-37.03%704K313.58%1.68M-86.38%38K-1,891.38%-1.04M-92.02%30K
-Change in other current liabilities 112.81%1.59M96.61%-753K-109.04%-354K-41.14%3.09M-159.60%-385K-735.48%-12.43M-531.35%-22.24M468.49%3.92M85.98%5.24M131.54%646K
Cash from discontinued investing activities
Operating cash flow 22.69%127.04M390.17%74.58M381.37%47.58M-145.03%-15.07M-55.64%19.95M-43.55%103.55M-57.54%15.21M-69.55%9.89M-4.28%33.47M-43.89%44.99M
Investing cash flow
Cash flow from continuing investing activities 76.06%-34K1K87.50%-2K96.55%-2K54.41%-31K99.99%-142K099.93%-16K99.99%-58K-423.08%-68K
Net PPE purchase and sale 76.06%-34K--1K87.50%-2K96.55%-2K54.41%-31K47.99%-142K--067.35%-16K---58K-423.08%-68K
Net business purchase and sale ----------------------0--0--0--------
Cash from discontinued investing activities
Investing cash flow 76.06%-34K--1K87.50%-2K96.55%-2K54.41%-31K99.99%-142K--099.93%-16K99.99%-58K-423.08%-68K
Financing cash flow
Cash flow from continuing financing activities 100.20%216K100.82%122K0100.18%88K100.04%6K-138.60%-106.97M70.75%-14.89M63.79%-27.16M-112.37%-49.37M-490.73%-15.56M
Net issuance payments of debt --0--0--0--0--0-138.33%-115M40.00%-15M66.67%-25M-112.50%-50M---25M
Net common stock issuance ----------------------0----------------
Proceeds from stock option exercised by employees -98.04%216K-39.90%122K--0-88.25%88K-99.94%6K73.24%11.01M-79.66%203K--0-45.17%749K152.73%10.06M
Net other financing activities --------------------89.78%-2.98M99.67%-90K---2.16M---121K---616K
Cash from discontinued financing activities
Financing cash flow 100.20%216K100.82%122K--0100.18%88K100.04%6K-138.60%-106.97M70.75%-14.89M63.79%-27.16M-112.37%-49.37M-490.73%-15.56M
Net cash flow
Beginning cash position -3.90%88.56M59.17%140.41M-12.01%92.85M-10.74%108.48M-3.90%88.56M-85.99%92.15M-20.86%88.21M-40.25%105.52M-83.62%121.54M-85.99%92.15M
Current changes in cash 3,670.75%127.23M22,743.43%74.7M375.24%47.58M6.16%-14.98M-32.13%19.93M99.37%-3.56M101.70%327K73.47%-17.29M97.18%-15.97M-65.10%29.36M
Effect of exchange rate changes -928.13%-329K1,571.43%351K0.00%-26K-1,168.63%-647K-129.17%-7K39.62%-32K142.00%21K-766.67%-26K---51K--24K
End cash Position 143.29%215.46M143.29%215.46M59.17%140.41M-12.01%92.85M-10.74%108.48M-3.90%88.56M-3.90%88.56M-20.86%88.21M-40.25%105.52M-83.62%121.54M
Free cash flow 22.83%127.01M390.18%74.58M382.13%47.58M-145.11%-15.07M-55.64%19.92M-43.54%103.41M-57.29%15.21M-69.55%9.87M-4.45%33.41M-43.96%44.92M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More